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Abstract: In the past twenty years marine biotoxin analysis in routine regulatory monitoring has
advanced significantly in Europe (EU) and other regions from the use of the mouse bioassay (MBA)
towards the high-end analytical techniques such as high-performance liquid chromatography (HPLC)
with tandem mass spectrometry (MS). Previously, acceptance of these advanced methods, in pro-
gressing away from the MBA, was hindered by a lack of commercial certified analytical standards for
method development and validation. This has now been addressed whereby the availability of a
wide range of analytical standards from several companies in the EU, North America and Asia has
enhanced the development and validation of methods to the required regulatory standards. However,
the cost of the high-end analytical equipment, lengthy procedures and the need for qualified person-
nel to perform analysis can still be a challenge for routine monitoring laboratories. In developing
regions, aquaculture production is increasing and alternative inexpensive Sensitive, Measurable,
Accurate and Real-Time (SMART) rapid point-of-site testing (POST) methods suitable for novice end
users that can be validated and internationally accepted remain an objective for both regulators and
the industry. The range of commercial testing kits on the market for marine toxin analysis remains
limited and even more so those meeting the requirements for use in regulatory control. Individual
assays include enzyme-linked immunosorbent assays (ELISA) and lateral flow membrane-based
immunoassays (LFIA) for EU-regulated toxins, such as okadaic acid (OA) and dinophysistoxins
(DTXs), saxitoxin (STX) and its analogues and domoic acid (DA) in the form of three separate tests
offering varying costs and benefits for the industry. It can be observed from the literature that not
only are developments and improvements ongoing for these assays, but there are also novel assays
being developed using upcoming state-of-the-art biosensor technology. This review focuses on both
currently available methods and recent advances in innovative methods for marine biotoxin testing
and the end-user practicalities that need to be observed. Furthermore, it highlights trends that
are influencing assay developments such as multiplexing capabilities and rapid POST, indicating
potential detection methods that will shape the future market.
Keywords: marine toxins; methods of analysis; SMART diagnostics; POST; multiplex detection
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1. Introduction
Bivalve mollusc production (e.g., mussels, oysters, scallops, and clams), represents a
significant proportion of the seafood industry in Europe and indeed worldwide, estimated
to be 17.7 million tons in 2018 [1]. Global exports of molluscs were estimated to be
10.6 billion USD in 2017, with European exports accounting for 20% of global trade. The
top European producers are Spain, France, the Netherlands, the United Kingdom, Italy,
Portugal and Ireland [2,3]. The production of bivalve molluscs is an important contributor
to local economies [1]; however, it is frequently hindered by contamination with marine
biotoxins produced naturally by various microalgal species during harmful algal blooms
(HABs). HABs typically occur in the warmer months and can have a devastating socio-
economic effect and impact on public health [4]. Economic losses caused by HABs can
be high, as for example in 2016, the United States seafood industry reported a predicted
900 million USD annual loss due to HABs [5] and are related but not limited to significant
delays in shellfish harvesting and commercial sales, the potential destruction or lengthy
depuration processes if available of valuable shellfish/fish stock, delayed seeding of new
stock, covering of healthcare costs incurred from sick consumers, and in consequence
reduced consumer confidence [4] (Figure 1).
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Figure 1. Economic impact of HABs on seafood production, public health, touris recre ts related to
monitoring and detection.
In relation to the importance of monitoring biotoxins, millions of dollars are spent each
year to prevent HAB events from impacting upon shellfish consumer safety [4]. Therefore,
the development of new robust POST methods for the detection of biotoxins is becoming
of significant importance especially for food business operators who need a rapid result
from harvested shellfish batches.
Shellfish production can be affected by a number of marine biotoxin groups. Table 1
lists t se marine toxins along with the harmful phytoplankton species associated with
their production.
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Phytoplankton sampling for species identification and counting using light microscopy
for threshold levels is for most part the precursor for toxin testing in regions of harvest [6].
New approaches to light microscopy using molecular microarrays for determining species
have been developed [22,23] as has an electrochemical biosensor for determining toxic
algae [24]. Similarly, colour remote sensing methods such as autonomous vehicles and
satellite imagery are increasingly being investigated as early warning approaches to pre-
dict and determine blooms [25,26] and the use of citizen science smartphone apps are
being evaluated to determine water quality [27]. European Commission Regulation No
853/2004 [28] legislates that all shellfish produced must be routinely monitored and tested
for the presence of regulated marine toxins before they can reach market. Therefore, al-
though phytoplankton monitoring may allow for informed decisions on bed locations
and harvesting both regulators and fishermen require instrumental chemical detection
methods to detect toxins to be compliant to the legislation for food safety purposes. This
EU legislation focuses on three main groups named originally by their symptoms, specifi-
cally amnesic shellfish poisoning (ASP), diarrhetic shellfish poisoning (DSP) and paralytic
shellfish poisoning (PSP) as the key regulated groups, as well as additional lipophilic toxins
incorporating azaspiracids (AZAs), yessotoxins (YTXs) and pectenotoxins (PTXs) [28–32].
Current legislation dictates that bivalve molluscs placed on the market for human con-
sumption must not exceed the set action limits (Table 1) or the shellfish is deemed not safe
for human consumption and the shellfish harvesting areas are closed until toxin levels
drop and two successive compliant tests are recorded [32]. These action limits are not
exhaustive and do not cover many of the newly emerging toxins, such as cyclic imines
(CI), tetrodotoxin (TTX), palytoxin (PLTX) and ciguatoxins (CTX) for shellfish production.
However, the legislation states that fish containing paralytic agents or CFP must not be im-
ported into the EU. For several emerging toxins, there is simply not enough data describing
the short- and/or long-term health consequences of exposure to these compounds (Table 1)
due to the unavailability of analytical standards and lack of toxicological assessment, but
as more research is performed, standards become available and more data is generated
regarding toxin occurrence and exposure, action limits may potentially be set to include
more toxin groups [33]. The European Food Safety Authority (EFSA) opinions on the risk
related to tetrodotoxin, palytoxin, brevetoxin, cyclic imines and ciguatoxin consumption
have been published. Due to changes in climate and species migration existing, EU regu-
lated toxins are showing up in new regions across the globe whilst currently non-regulated
toxins of concern are emerging in new areas and already known toxin hotspots [34–40].
As such, it is important that shellfish producers are well prepared to screen for additional
toxins as and when new regulations are enacted.
Many marine toxin groups have multiple analogues each with varying levels of
abundance and toxicity. For example, over 50 analogues of STX have been identified which
have been categorized depending on their chemical structures [41,42]. Furthermore, new
toxin analogues are periodically being discovered; for example, unique AZA analogues
have been identified as recently as 2017 [43–45]. Each analogue can be more or less toxic
than the parent toxin, therefore, the Panel on Contaminants in the Food Chain (CONTAM)
group within EFSA recommends calculating Toxicity Equivalence Factors (TEFs), however,
there is still no easy way to do this without in-depth toxicological assessments.
Shellfish producers are often in a difficult position; consumers want freshly caught
shellfish, however, with current technologies, it can take between 24 h up to several days
from point of sample to return a result to the fisherman. This can be in part dependent
on location of the farm relative to the regulatory laboratory but also in part for the time
required for regulatory laboratories to process samples and determine the toxin load. By
example this delay in turnaround time of analysis caused substantial financial losses for
the Australian shellfish industry in 2011 [46]. On occasions the sample for analysis for
the harvest may have been taken just prior to a developing HAB at the site and although
a result may come back negative, within 24–48 h, a given turnaround time for analysis,
the planned harvest can then be contaminated to levels above the maximum permitted
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level. Following the negative result the produce will be harvested, distributed and eaten
whereby thereafter following illness outbreaks, toxin contamination is detected. Similarly,
the harvest can be taken at the same time as the official control sample and distribution
of shellfish produce underway whereby expensive and reputational damaging recalls are
then necessary 24–48 h later following a positive result and consumption of unsafe shellfish.
Either scenario can be devastating for both shellfish consumers and producers. Though it
should be stated that it is the duty of the food business operator to ensure the food is safe
for consumption not the official control laboratory and produce should not be harvested or
released until deemed safe. It is also therefore in the best interest of the producer as the
food business operator to be able to conduct their own real-time end-product testing to
regulatory accepted standards to ascertain if their product is safe to harvest. In relation to
these described constraints, recent advances in detection methods for marine biotoxins and
improving standards in the food industry can be drivers for change.
This review outlines and compares the current technologies trialed, applied and com-
mercially available for marine toxin detection and explores potential emerging technologies
that may be deemed fit for purpose for producers to screen their harvest before distribution,
but also for regulators and stakeholders for monitoring and surveillance along the seafood
supply chain.
2. Detection Methods for Marine Toxins
There are various methods of analysis for marine biotoxins which can be classified into
biological, biochemical and chemical based methods (Figure 2) though not all are accepted
as official control methods for regulatory purposes and with some acknowledged as proofs
of concept for new technological applications. Official control laboratories carry out official
testing procedures on behalf of a competent authority following set legislation on accepted
methodologies and action limits to stringent standards and validated accreditation. POST
as end-product testing procedures are not necessarily following or approved by legislation
but can be used by the fisherman for product release as a means to ensure compliance
to safety measure for toxin testing for harvest and distribution. The challenge is that the
approaches that can be applied for POST end-product testing are often unvalidated and
not shown to be fit for purpose for the end user. Therefore, their acceptance for use can
be deterred until fully proven in both laboratory and at point of site in their suitability for
use. However, it is important to emphasize that the EC Regulation 519/2014 [47] which
provided additional information on the validation requirements for semi-quantitative
screening methods is driving forward more SMART sensor approaches for approval. The
list of currently available end-product testing technologies is provided in Table 2.
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Table 2. The list of available end-product testing technologies.
Method Additional Materials Required(Not Included in Main Kit)
Time per Sample
(Sample Preparation) Cost





Pipette(s) w. disposable tips
Absorbent towels
Timer
Sample extraction kit 3
90 min




Sample extraction kit 3
35–45 min




microarray analysis platform (MCR3)
Pipette(s) w. disposable tips
Sample extraction kit 3
20 min
(20 min) ££ 2
Assays must be validated in single- and multi-
laboratory studies
MCR3 technology is not portable for on-site
testing by end-users
SPR
Biacore™ Q optical biosensor
Pipette(s) w. disposable tips
Sample extraction kit 3
10 min
(60 min) £££ 3
Assays have been validated in single-laboratory
studies to AOAC standards
SPR technology is suitable for use by novice
end-users
High cost
Wizard driven software for use/maintenance
Electrochemical
Electrochemical analyser
Pipette(s) w. disposable tips
Sample extraction kit 3
10–45 min
(30–60 min) ££ 2
Assays must be validated in single- and multi-
laboratory studies
Challenging set-up for end users
Planar waveguide
Waveguide reader
Pipette(s) w. disposable tips
Sample extraction kit 3
20 min
(60 min) £ 1
Assays must be validated in single- and multi-
laboratory studies
Software for data analysis not suitable for novice
end user
1 £ = Minimal additional equipment required, ££ = Some specialised equipment required, £££ = Expensive, specialised equipment required; 2 1 = No training or facilities required, 2 = Minimal training and
facilities required, 3 = Technical staff and facilities required; 3 Common requirements include a blender, weighing scales, a roller mixer, a centrifuge, a hot plate or hot bath, filters. Extraction buffers vary
dependent on the assay (i.e., varying concentrations of NaAc, MeOH, Acetic Acid, or NaOH with HCl); 4 Many DSP kits require a 60-min alkaline hydrolysis step to accurately assess DSP concentration.
Sensors 2021, 21, 2499 9 of 34
3. Methods for Official Control Testing
3.1. Mouse Bioassay (MBA)
Until recently, for the past 70 years, bioassays such as the MBA have been the reference
methods worldwide for identification of DSP [48] and PSPs [49]. MBA methods involve
intraperitoneal injection of replicate shellfish extracts to mice and measuring either the
time of death after injection, for a direct measure of PSP toxicity, or mortality/morbidity or
clinical signs of toxin exposure for DSP. Aside from the obvious ethical issues, testing for
the presence of PSP and DSP using the MBA, suffered from low sensitivity, inaccuracies due
to matrix interferences, whilst offering no information regarding the toxin profile present
in the shellfish extract or the toxin(s) responsible for death. Following implementation of
EU Directive 2010/63 (on the protection of animals used for scientific purposes) which
prohibits use of an animal test when an accepted alternative exists [50], MBA have been
gradually replaced in recent years in the EU (i.e., in UK and Ireland MBA is not in use)
with alternative non-animal methods for shellfish toxin detection. Moreover, as a result
of the scientific, technical, and ethical limitations, countries such as Australia, Canada
and New Zealand no longer use the MBA test for routine toxicity testing of shellfish.
However, this progress in moving away from the MBA was not without its challenges in
method development, validation and translating toxicity to the MBA, with equivalency
factors [41,51]. Following implementation of Commission Regulation (EU) 2017/1980,
the MBA is no longer the reference method for detecting PSP toxins in the EU [32] and is
not listed in the National Shellfish Sanitation Program (NSSP) ‘Guide for the Control of
Molluscan Shellfish’ as a method to test for DSP or ASP. This change should ensure the
complete replacement of the MBA at the EU level.
3.2. Chemical Methods
In 1997, the Council of the European Union adopted Directive 97/61/EC (Council of
the European Union, 1997) [52], allowing liquid chromatography (LC) with UV detection
(LC-UV) to be used to screen for DA as the main ASP toxin [53]. In 2011, the European
Commission adopted Regulation (EU) No 15/2011 (European Commission, 2011) [31] to
approve LC with tandem mass spectrometry (LC-MS/MS) for the screening for lipophilic
toxins, including DSP [54]. More recently, the European Commission adopted Regulation
(EU) No 2017/1980 [32], accepting the so-called Lawrence method (AOAC 2005.06 official
method of analysis) as the EU reference method for PSP detection. The Lawrence method
involves liquid chromatography (LC) with pre-column oxidation and fluorescence detec-
tion [55,56]. Alternatively, LC with post-column oxidation and fluorescence detection has
been approved for PSP detection in the United States and Canada [57].
The technique of electrospray ionization (ESI) liquid chromatography-mass spectrome-
try (LC-MS) has proven to be one of the most powerful tools for the detection, identification
and quantification of marine toxins. Suzuki et al. [58] recently conducted a review on
LC-MS analysis of marine toxins which concluded that similar MS/MS fragmentation
patterns obtained by different equipment demonstrate that MS/MS spectra of marine
toxins could be useful fingerprints for identification of toxins. Further improvements in
these methods are always being considered with new combined all toxin detection methods
being developed and validated for use. Rodríguez et al. [59] recently developed an ultra
performance liquid chromatography (UPLC)-MS/MS method for the identification and
quantification of hydrophilic and lipophilic marine toxins. The method included the deter-
mination of 14 toxins of the STX group, 15 lipophilic toxins, 15 toxins of the TTX group and
DA. Validation studies demonstrated acceptable method performance characteristics for
linearity, and repeatability between-batch and within-batch. The study demonstrated that
the UPLC—MS/MS method provides a potentially useful tool to determine hydrophilic
and lipophilic toxins and therefore it could be appropriate for interlaboratory validation.
Chemical detection methods incorporating chromatographic separation and a range
of detectors are now the current diagnostic gold standards for marine toxin detection:
they are accurate, sensitive, and provide information on the specific toxins for whichever
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standards are commercially available. Similarly, sample preparation methods can be
complex whereby after solvent extraction, the crude shellfish extract may be submitted to
solid-phase extraction (SPE). Clean-up steps are usually employed to either pre-concentrate
extracts to enhance assay sensitivity, or to remove matrix co-extractives which interfere with
the analysis. SPE involves dissolving or mixing the analyte (s) of interest in a liquid sample
(mobile phase) and then passing that sample over a solid chromatographic component
(solid phase). The desired analytes will either flow through the solid element, remaining in
the mobile phase, or be retained on the solid phase and subsequently eluted for testing.
SPE clean-up is critical for the liquid chromatography fluorescent detection (LC-FLD) or
LC-MS/MS analysis of PSP toxins [55,60] and can be used for reducing matrix interferences
during ASP analysis [61]. These et al. [62] have used SPE to enrich OA, AZA, PTX2, and
YTX up to a factor of 10, increasing the sensitivity to low level toxins and reducing the
amount of sample needed for testing. Gerssen et al. [63] performed SPE using polymeric
sorbents, coupled with LC under alkaline conditions, to effectively reduce matrix effects
with methanolic extracted hydrophilic marine toxins when measured by LC-MS/MS [63].
For regulatory high throughput monitoring of lipophilic toxins by LC-MS/MS, however,
SPE is not typically applied. That said though, they are also specialized and expensive
procedures: they require trained staff, a large range of disposable reagents, bulky and
expensive laboratory equipment, and dedicated laboratory facilities. Therefore, they are
limited to the regulatory or large commercial laboratory settings, and as such, they are
not available to producers for rapid, on-site testing during harvesting. However, with
the immediate challenge in replacing the mouse bioassay as the driver for innovation in
alternative methods now achieved from a regulatory perspective, the current diagnostic
gold standard LC and LC-MS/MS based methods are now established as a benchmark to
compare other tests.
3.3. Receptor Binding Assay (RBA)
Functional assays such as receptor binding assays were also examined and utilized to
move away from the use of animal testing for toxicity determination [64]. The RBA relies
on the specific recognition of an analyte via specific receptors which are often endogenous
targets of the analyte. Doucette et al. [65] described a microtiter plate-based RBA for PSP
testing of bivalve mollusc species where a STX standard or sample is added to a 96-well
plate, followed by tracer-tagged STX, and lastly diluted rat membrane homogenate. The
membrane homogenate is derived from rat brains and therefore contains the biological
target of STX, voltage-gated sodium channels on nerve cells. The STX or analogue binding
to the sodium channel is dependent on the toxin’s affinity to the endogenous target, and
because toxin’s affinity for biological receptors is a direct reflection of its toxicity, the
RBA uniquely gives an indication of the toxicity of a sample, as well as the amount of
toxin present. This RBA has been successfully validated in both single-laboratory [66] and
in multi-laboratory [67] studies for PSP detection. This assay is currently validated for
screening of mussels and clams for PSP toxins in the US and studies have demonstrated
performance characteristics for oysters, mussels and clams in Europe [68]. Such tests have
been implemented in aquaculture regions of the developing world as opposed to Europe as
health and safety measures in Europe for the use of radioactive materials causes restrictions
in its use.
Alonso et al. have taken the determination of toxicity one step further by employ-
ing automated patch clamp sensors [69]. Automated patch clamp sensors can assess
action potential propagation along neurons and have therefore been used to quantify the
functional inhibition of neuronal signaling by 9 different PSP analogues. Furthermore,
Alonso et al. [69] used mouse cell lines transfected to express various human sodium
receptor subtypes. This has the great advantage of avoiding the risk of species-dependent
differences in toxin susceptibility.
DSPs are potent protein phosphatase 2A (PP2A) inhibitors and thus very well suited
to the RBA format [70]. Indeed, Zeulab produce the OkaTest kit, a commercially available
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DSP RBA that is also currently validated as a supplementary test to the reference screening
method [71]. The OkaTest kit comes with PP2A and a PP2A substrate (p-Nitrophenyl
phosphate). It is a colorimetric assay and it takes 1 h to set up, and 30 min to run. It has
been validated in molluscs in both single [72] and multi-laboratory [73] studies for DSPs
detection, and therefore can be used as a supplementary test to the reference method for
determination of DSPs according to the Commission Regulations (EC) No. 853/2004 and
No. 15/2011 [28,31].
RBAs are also in development for other toxins. For example, Aráoz et al. have
designed an RBA capable of detecting for anatoxins (ANTX) in drinking water utilizing
nicotinic acetylcholine receptors (nAChRs) [74,75]; ANTX is a potent agonist of nAChRs.
Instead of rat brain homogenate, this assay uses Torpedo electrolyte membranes, as these
membranes are rich in nAChRs. Fonfría et al. have further developed this method to detect
GYM and SPX in the nM range [76]; Rodríguez et al. subsequently optimized the assay
for high-throughput [77]. Furthermore, Hardison et al. have developed a similar RBA to
detect CTX from reef fish tissue. Their assay can sufficiently quantify CTX well below the
limit set by the USFDA. Additionally, their CTX RBA is reported to correlate well with
other methods [78].
Pelin et al. [79] have taken a different approach in their PLTX assay. Instead of
competitive-based inhibition, their assay was designed as a sandwich; PLTX is captured
by receptors on immobilized HaCaT cells and then detected with labelled antibodies.
This assay is more sensitive (32 pg/mL), more specific, and significantly faster than other
PLTX immunoassays, and it has been validated by inter-laboratory studies in mussel
tissue samples.
RBAs can be an accurate and sensitive means of measuring toxicity in shellfish samples,
but as with the MBA does not return information on individual toxins present, preventing
determination of toxin profiles. Additionally, other contaminants can act on these receptors
whereby specificity of the test to one toxin family or other chemical contaminants perhaps
also present cannot be determined and competing interfering compounds can present
misleading results. Also, specialist equipment and reagents are required and the inclusion
of the receptors as resources from the use of animals remains to have ethical implications, all
of which preclude the uptake of these assays and their application on-site for the producers.
4. Methods for End-Product Testing (EPT)
4.1. Immunoassays
4.1.1. Enzyme-Linked Immunosorbent Assays (ELISA)
ELISAs rely on the highly specific and sensitive nature of antibodies to detect the
specific toxin structures and quantify the toxin concentrations in a solution. There are
a number of ELISA variations, including direct and indirect, however, the competitive-
indirect ELISA is the most popular for shellfish toxin screening [80,81]. In this format, an
analytical standard of toxin is immobilized on a 96-well microtiter plate. Next, the sample is
added, followed by the primary antibody, which is specific to the toxin. Next, a secondary,
enzyme-conjugated antibody, which recognizes the primary antibody, is added, followed
by an enzymatic solution that reacts with the enzyme-conjugated secondary antibody. A
colorimetric readout is given; this is inversely proportional to the amount of toxin present
in the sample; toxins in a contaminated sample will compete with the plate-bound toxin
for the primary antibody. A weaker colour indicates less primary antibody binding to the
plate-bound toxin, because there is more toxin in the sample blocking binding (Figure 3).
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   Toxin 
Company Product  Type DA OA DTXs STX GTXs TTX BTXs CTXs 
Bioo Scientific  MaxSignal®® Domoic Acid  ELISA √         
 MaxSignal®® Okadaic Acid  ELISA  √  *      
 MaxSignal®® Saxitoxin  ELISA    √  *    
Zeulab DomoTest ELISA         
 OkaTest RBA  √  *      
 Saxitest ELISA         
Creative Diagnostics Domoic Acid Kit ELISA √         
 Tetrodotoxin Kit ELISA      √    
Mercury Science Domoic Acid Kit ELISA √         
 Domoic Acid Field Kit DOT 1 √         
 Total Saxitoxin Kit ELISA    √  *    
Abraxis Domoic Acid ELISA Kit ELISA √         
 Okadaic acid ELISA Kit ELISA  √  *      
 Okadaic Acid PP2A Kit RBA  √  √       
 Saxitoxins Shipboard Kit  ELISA    √  −    
 Brevetoxin (NSP) Test ELISA       √   
Figure 3. Inhibition-based competitive enzyme-linked immunosorbent assay. (A) The toxin of interest is immobilized in
the solid phase on a microtiter plate well. (B) Sample is mixed with a labelled antibody and added to the well. (C1) If the
toxin of interest is present in the sa ple, it ill co pete ith the i obilized toxin to bind to the labelled antibody. ( 2)
If the toxin of interest is not present, the label ed antibody wil bind to the immobilized toxin. (D) Unbound antibody is
washed out and the wel s imaged. ( 1) positive result is indicated by the lack of signal, because toxin in the sa ple has
prevented the antibody from binding, whereas (D2) a negative result is indicated by a signal, because the labelled antibody
has not been inhibited from binding to the immobilized toxin.
I t e early days of ELISA develop ent, Garth aite et al. ro c a nu ber of
IS s ca able of etecting , , , , strate t e f si ility
f an ELISA-based screeni g sy tem for identifying contaminated shellfish [82]. Currently,
there are multiple op ons for commercial ELISA kits available for us in end-product test
ing (Table 3). These includ tests by Bioo Scientific, Z ulab, Cr ative Diagnostics, Mercury
Sci nce, Abraxis, Marbionc, Uni i test, Beacon, R-Biopharm, and Biosense Laboratories. A
summary of these is outlined in Table 3, a d more details about s me of these can be found
in McLeod t al.’s review [83].
Although ELISA technology is now substantially dated compared to novel biosensor
approache it is still the most highly ut lized rapid screening assay in food and clinical
diagnostics worldwide due in part to the expense and complexities in acceptability of
other methods.
Due to the wide range of analogues of high potency and varying toxicities the paralytic
shellfish toxins were one of the most challenging toxin groups for ELISA development.
The first antibodies were developed to saxitoxin (STX) in 1964 by Johnson et al. [84] and
the first ELISAs only utilized antibodies raised against STX. However, due to the highly
specific nature of antibodies, these tests were not able to accurately assess total PST levels
in a sample. For example, neosaxitoxin (NEO), the second most toxic STX congener, would
often be underreported in these assays [85–87], and as such, multiple assays had to be run
side-by-side to accurately assess total PSP levels [88].
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Table 3. A list of commercially available marine toxin detection kits.
Toxin
Company Product Type DA OA DTXs STX GTXs TTX BTXs CTXs
Bioo Scientific MaxSignal®® Domoic Acid ELISA
√


















Mercury Science Domoic Acid Kit ELISA
√

Domoic Acid Field Kit DOT 1
√

Total Saxitoxin Kit ELISA
√
 *
Abraxis Domoic Acid ELISA Kit ELISA
√

Okadaic acid ELISA Kit ELISA
√
 *





Saxitoxins Shipboard Kit ELISA
√
 −
Brevetoxin (NSP) Test ELISA
√









Unibiotest Tetrodotoxin ELISA Test ELISA
√

Tetrodotoxin Rapid Test LFIA
√






R-Biopharm EuroProxima Domoic Acid ELISA
√













Biosense®® Laboratories ASP ELISA Kit ELISA
√

DSP ELISA kit ELISA
√
 −
PSP ELISA kit ELISA
√
 −
Neogen Reveal®® 2.0 for ASP LFIA
√






Reveal®® 2.0 for PSP LFIA
√
 *









1 A dot blot assay functions similar to an ELISA but on a membrane rather than a well. 2 DTX-1 and DTX-2, but not DTX-3
√
Kit available for detecting toxins−Not able to detect toxins * Information unavailable.
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To simplify this analysis, Huang et al. [89] used two antibodies within a single heterol-
ogous ELISA to produce an assay capable of detecting both STX and NEO at the same time.
By combining two antibodies, Huang et al. [89] were able to increase the sensitivity and
specificity of their test to detect total PSP levels similar to the MBA. McCall et al. [90] have
developed a similar ELISA capable of detecting STX-analogues using a single monoclonal
antibody (mAb) that recognizes STX and NEO, but does not cross-react very well with
GTX1/4 nor GTX2/3. In this assay, GTX must be converted to STX by incubating the sample
with L-cysteine. A number of other STX ELISA kits have been developed, as reviewed [83].
Details regarding the cross-reactivities of the test response are particularly important given
the wide variability in PST analogues present in different geographical regions [91] and
their varying toxic potency. Cross reactivities are known to vary significantly between
different commercial ELISA kits. Five ELISAs were compared in terms of their qualitative
and quantitative performance, with ELISA results assessed against the regulatory LC-FLD
method. Performance varied considerably between the commercial assays, specifically
with some under-estimating and others over-estimating toxicity due to cross-reactivity
related issues particularly relating to the presence of PST analogues such as GTX1/4 and
linearity problems [91].
For DSP testing of the okadaic acid (OA) group of toxins, including OA and the
Dinophysis (DTX) toxins, many ELISA kits also suffer from cross-reactivity issues [92–96].
Anti-OA antibodies can have limited cross-reactivity with DTXs, especially DTX-2 [97].
Given the potential for a high proportion of OA-group toxins to be present in shellfish
as acyl-esters, ELISAs which do not incorporate an alkaline hydrolysis step to convert
esters into freely-occurring OA and DTXs will potentially significantly under-estimate
total OA-group toxicity [98]. Various studies have assessed the performance of commercial
DSP ELISAs, in comparison with the LC-MS/MS DSP regulatory method. Differences in
performance were reported, with most tests exhibiting issues relating to low cross-reactivity
to DTX2 [99–101].
As the simplest of the EU regulated toxin groups in relation to the single congener
domoic acid to be reported there have been numerous ELISA kits developed for ASP
detection [81,102–111]. Biosense currently has the only commercial ELISA kit for ASP
detection that has been validated in single [112] and multi-laboratory [113] studies to
AOAC standards. The kit is based on antibodies developed by Garthwaite, et al. and has
a limit of quantitation of 38 ng/g flesh [102]. Uniquely, Shaw et al. isolated recombinant
sheep single-chain antibody fragments (scFvs) to create a novel ELISA [114]. This assay was
tested with naturally contaminated scallop tissue and correlates well with standard high-
performance liquid chromatography (HPLC) assay results, although the ELISA tended to
underestimate DA content. Johnson et al. compared the performance of three ELISA kits
for DA detection and quantitation, with all providing an acceptable level of qualitative
detection, but with variable quantitative performance [99].
Ling et al. developed an ELISA capable of detecting BTX at levels as low as 14 ng/mL [115].
This assay was tested with a wide range of artificially spiked shellfish samples, including
clams, mussels, oysters, and scallops and found to have an average toxin recovery rate
of 89 ± 2%. Unfortunately, naturally contaminated shellfish samples were not tested.
Briggs et al. used sheep polyclonal antibodies (pAbs) to develop an ELISA capable of
detecting YTX and a broad selection of YTX analogues. This assay reports higher YTX levels
in mussel flesh compared to LC-MS, however, this could be because there are analogues
present in the extract that the ELISA detects but the LC-MS does not [116].
Samdal et al. have developed a competitive ELISA capable of detecting AZA and
analogues in shellfish samples and algal cells. It has a quantitative range of 0.45–8.6 ng/mL
and limit of quantitation (LOQ) of 57 µg/kg in shellfish, satisfying the AZA maximum
permitted level (MPL) of 160 µg/kg [117]. Reverté et al. have developed a maleimide-
based ELISA (mELISA) capable of detecting TTX in pufferfish. In this assay, TTX is
immobilised on maleimide-activated dithiol-carboxylate monolayers; this strategy results
in more structured antigen immobilisation and increases assay fidelity [118]. This assay
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was further refined for use in oysters and mussels [119], and both assays are capable
of detecting TTX well below 2 µg/g of flesh, the permissible limit set by the Japanese
government for puffer fish.
Tsumuraya et al. have developed a sandwich ELISA whereby CTX is captured between
immobilised and labelled antibodies. Their test can detect four Pacific CTX (P-CTX)
congeners at concentrations as low as 1 pg/mL [120]. The European Commission does
not currently have an MRL set for CTX, and thus official, regular testing does not occur,
however, the EU Community Reference Laboratory on Marine Biotoxins (CRLMB) has
recommended a guidance level of 40 ng/kg flesh [121]. On the other hand, the United
States Food and Drug Administration has established guidance levels of 10 ng/kg flesh
of Caribbean CTXs (C-CTX) and 100 ng/kg flesh of Pacific CTXs (P-CTX), and uses a
two-tiered testing protocol involving (1) a mouse neuroblastoma (N2a) cell assay and (2)
an LC-MS/MS assay [122,123].
Boscolo et al. have developed a sandwich ELISA capable of detecting PLTX and
42-OH-PLTX in natural samples as low as 1 ng/mL, however, unfortunately the assay
could not be assessed with other PLTX analogues [124]. The EFSA advises an MRL of
30 ug/kg flesh, however, there is currently no legislation requiring PLTX testing in Europe.
There are a large number of ELISA tests developed and commercially available for
regulated toxins. There are also many tests developed for non-regulated/emerging toxins.
Even still, ELISA is not a widely accepted screening method for all marine toxins, in part
due to the sensitivity and specificity of a test relative to the congeners in a toxin group
and the lack of available toxin standards to calibrate the method. Shellfish toxins from
some classes can be highly lethal in small doses, and thus some are listed as controlled
substances, most notably STX and analogues. This limits their availability as reference
reagents in competitive-based assay formats and greatly increases production costs of
these types of test. Additionally, ELISAs can be time consuming procedures with many
steps whereby the risk for human/operator errors increases. They require availability of
laboratory instrumentation such as plate readers, incubators and shakers, and protocols
for some of the assays are not as easy to follow as some other end product tests [91,99].
Although there are a significant number of ELISA applications commercially available the
restrictions in demonstrating the methodology to be fit for purpose in single laboratory and
interlaboratory validation remains an essential requirement in legislation for their uptake
for regulatory purposes. The time and cost of conducting these studies by a commercial
entity to regulated standards, such as AOAC validation protocols, therefore has to be
viable for the business entity in terms of potential sales value thereafter whereby due to
the limited size of the market for sales there can be a catch 22 in uptake due to lack of
validation for regulatory purposes. Therefore, with few exceptions these tests are deemed
either as a research tool or if considered as a POST for end product testing they are only
applied for use as a screening tool by the food business operators at their own risk with
limited data available on their validity.
4.1.2. Lateral Flow Immunoassay (LFIA)
The LFIA has recently become a very popular assay format for all kinds of diagnostic
testing as a single analysis portable tool though the portability or novice end user applica-
tion of such a device can be restricted with the sample preparation required prior to usage
of the device. Like the ELISA, the LFIA utilizes specific antibodies to recognize toxins in a
sample. There are also several types of LFIAs; typically, shellfish screening is done with
a competitive-based assay. An LFIA comprises a series of overlapping membranes that
function based on capillary flow. At one end of the test, a conjugated antibody is sprayed
onto a sample pad whilst on the other end of the test, toxin is immobilized on a membrane
(e.g., nitrocellulose) at the test line. Liquid sample is applied to the sample pad, where
the conjugated antibody will interact with any toxin in the sample. Capillary action then
pulls the complex along to the test line where any free conjugated antibody will bind to the
toxin. Like the competitive ELISA, the amount of binding is inversely proportional to the
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amount of toxin present in the sample. The antibody may be conjugated with any num-
ber of signal molecules, including colloidal gold particles, nanorods, chemiluminescence,
or fluorescence.
Jawaid et al. have developed a qualitative LFIA, utilizing colloidal gold nanoparticles
for detection of PSTs in scallops, oysters, clams, mussels, and cockles. The test uses
a cocktail of antibodies raised against different paralytic shellfish toxins [125]. These
antibodies demonstrate broad cross-reactivity with 128.9% binding to NEO, 23.4% to
GTX2/3 and 55.6% of dcSTX, amongst others (relative to 100% STX binding). This assay
takes 15–20 min to prepare the samples, 5 min to complete the assay, and it was validated
in single-laboratory and multi-laboratory studies to AOAC standards, although there is
noted variability in mussel samples [46,126].
The same group has produced a similar assay for the assessment of ASP and
DSPs [127,128]. The DSP detection kit can detect OA-group toxins in scallops, clams,
and mussels [101] as well as oysters [91,100]. Neogen advertises an LOD of 160 µg/kg,
although values as low as 60 µg/kg can test positive [128]. This can be frustrating for
producers when their harvest is well below the action limit, but still testing positive by
LFIA. The assay also includes the alkaline hydrolysis step to liberate esterified OA-group
toxins. Scotia also produces a range of LFIAs for marine shellfish toxin detection, including
DSP, ASP and PSP test kits [99,129,130]. The Scotia PSP LFIA uniquely incorporates an
additional conversion step, to transform GTX1/4 and GTX2/3 toxins, with the former
in particular exhibiting very low cross reactivities, to NEO and STX respectively, thereby
decreasing the occurrence of false negative results [131]. The Neogen and Scotia kits are
qualitative, and the purchase of an optional test strip reader is advised. However, these
readers are also able to provide test result numbers which can be used to provide a semi-
quantitative indication of the levels of toxicity present [91,131] though this component is
not recommended by the kit manufacturer for end user use. A summary of commercially
available LFIAs is outlined in Table 2, and more details about some of these can be found
in McLeod et al.’s review [83].
Other groups have also developed prototype LFIAs for TTX and BTX. Uniquely,
Shen et al. used quantum dots and gold nanoflowers to create an LFIA that could detect TTX
concentrations as low as 0.2 ng/mL [132]. Ling et al. adapted their BTX ELISA (discussed
above) into an LFIA, however, unfortunately, the new LFIA format had significantly
reduced sensitivity (200 ng/mL) compared to the ELISA format (14 ng/mL) [115].
The LFIA format is robust, stable, and rapid (15 min). Also, it requires very little
technical expertise or experience. As such, it is a good candidate for on-site analysis.
Unfortunately, the current commercially available LFIAs are qualitative and the competitive
assay format requires a test strip reader to confidently read the results. Whilst a ‘yes’ or
‘no’ result can be simple to understand, more nuanced data can be helpful. For example,
if toxin is detected, an LFIA cannot determine how much is present, other than the semi-
quantitative indications provided by the automated scanners. Similarly, it can be difficult
to determine trends with an LFIA, such as, if a contamination incident is getting better
or worse over time on a positive or negative classification of result only. Similar to the
ELISA methods there are a number of commercial LFDs available but the same limitations
apply in their validation for regulatory purposes even as a screening tool. Performance
criteria for the validation of qualitative and semi-quantitative screening methods for certain
mycotoxins has been set in European Regulation (EC) 519/2014 whereby these could also
translate to methods for the screening of marine and freshwater toxins [47]. Demonstrating
the methods to be fit for purpose to accredited standards would improve their uptake for
use and commercial viability but as already stated there is a cost benefit analysis for the
diagnostics industry in doing so which currently prevents this. Researchers are therefore
conducting such studies to provide and enable timely solutions for the shellfish industry
and regulators for enhanced safety performance [46].
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5. Proof of Concept Biosensors
A number of prototype and commercial single and multiplex biosensors have been
evaluated for the purpose of marine toxins determination though steps from innovation
to the commercialization of these technologies for use in the laboratory or in the field has
not been forthcoming to date [133]. Similarly, several biorecognition molecules such as
antibodies, aptamers and other receptors for certain toxins detection have been evaluated
to be used on different handheld devices in their ability to be fit for this purpose. Among
the use of aptamers or other receptors, the application of antibodies as biorecognition
molecules was the most investigated for marine biotoxins detection on a wide range of
sensor platforms due to their specificity and sensitivity. Nonetheless, there are still obstacles
to reach the stage of commercialization of these sensing platforms, and similar to ELISA
or LFD development, the lack of full validation to the regulatory requirements for their
uptake in marine toxins detection shelves these technologies as a proof-of-concepts or
research tools at universities and research institutes.
5.1. Antibody-Based Biosensors
5.1.1. Flow-Through Microarrays
An alternative screening method developed by Szkola et al. exploits an automated
flow-through chemiluminescence microarray for simultaneously detecting DA, OA, and
STX in shellfish. Toxins are ‘spotted’ onto a polyethylene glycol-treated glass slide and a
mixture of the primary antibody and sample is added. Next, a horseradish peroxidase-
conjugated secondary antibody is added. The secondary antibody binds to the primary
antibody to produce a chemiluminescent signal [134].
This assay requires 15 min of sample preparation and takes 20 min to complete. The
microarray achieved a LOD of 0.4, 0.5 and 1 µg/L and recovery values of 61.6%, 86.2% and
102.5% for STX, DA and OA respectively in spiked shellfish samples. (Cross-reactivities
were not assessed for toxin analogues.) Furthermore, the readouts for this multiplex were
quantitative for OA and DA, but only semi-quantitative for STX. Notably, the microarrays
may be regenerated with the addition of an SDS-HCl buffer after the assay which allows
them to be re-used for a total of 25 measurements. Whilst rapid, relatively simple-to-
use, and offering multiplexing capabilities, the equipment required is too sophisticated
and cumbersome to be used in the field; it is about the size of a standard fume hood.
Additionally, glass slides are fragile and can be easily broken. Furthermore, similar to the
immunoassays described above, this is a competitive-based inhibition assay and thus it
suffers from the same drawbacks (qualitative).
5.1.2. Fluorometric Assays
Fraga et al. have developed a multi-detection, semi-quantitative immunoassay, using
a solid-phase microsphere-flow cytometry system based on the Luminex xMAP®® technol-
ogy. This assay is capable of detecting OA, DA and STX in mussels and scallops [135]. It is
also a competitive-based inhibition assay. The three toxins are conjugated to Fluorophore-
encoded Luminex microspheres, which are then mixed with sample, anti-toxin primary
antibodies, and reporter secondary antibodies. It is similar to the previous cited assays,
binding of the primary (and thus secondary) antibodies to the toxin-conjugated micro-
spheres is dependent on toxin levels present in the sample. High levels of sample toxin
reduce primary antibody binding to the microspheres, and thus result in a lower signal
when read by a Luminex 200 analyser. Using this approach, the authors could screen up to
40 samples per run, however, the runs themselves are not particularly rapid, owing to the
multiple 1-h incubation periods required for each group of samples during the preparation
phase. Also, similar to the fluorometric assay described above, Luminex technology is
large, expensive (particularly for the magnetic particles), and not suited to on-site testing.
Of note, the authors used a methanol/acetate buffer for solvent extraction and were
able to obtain recoveries of 80%, 90% and almost 100% for OA, STX, and DA respec-
tively. Inhibitory Concentration 50 (IC50) values were also reported: 5.58 ng/mL for STX,
Sensors 2021, 21, 2499 18 of 34
1.15 ng/mL for OA, and 1.92 ng/mL for DA. To date, this assay has not been assessed for
cross-reactivity to any of the various toxin analogues or other toxin groups.
This technology was also evaluated further for the detection of azaspiracid [136]
using a monoclonal antibody whereby applying the simple acetate/methanol or methanol
extractions yielded final extracts with no matrix interferences and adequate recovery rates
of 86.5% and 75.8%, respectively. Though limitations in its acceptability arise from the lack
of knowledge of cross-reactivity of the test with all azaspiracid congeners that can now be
determined by LC-MS/MS in real samples.
On the same note the application of using the technology for the determination of
cyclic imines using a receptor based assay has also been shown [137].
5.1.3. Surface Plasmon Resonance (SPR)
Since 2000, SPR biosensors have been employed for the detection of toxin analytes in a
variety of sample types [138–146]. A surface plasmon polariton is an electromagnetic wave
that runs parallel along a metal surface at its interface with the surrounding air or other
medium. The oscillations of those electromagnetic waves are highly sensitive to changes to
that metal surface, for example through binding of different molecules. When light is shone
through a prism, the angle of its refraction upon contact with the metal surface is dictated
by the oscillations of the surface plasmon polaritons. A sensor then measures the amount
of light that is reflected towards a given point which gives an indirect measurement of
how much material has bound to the metal surface. Many SPR biosensors use immune
recognition and, much like other immunoassays, they can be designed as direct, indirect,
or inhibition-based competition assays. Due to the highly sensitive nature of SPR, it is
imperative that there is no non-specific binding of molecules to the metal surface which
will influence the readout.
Yu et al. describe an inhibition-based competitive SPR assay for the detection of
DA [147]. DA is immobilized on mixed self-assembled monolayers (SAMs) on a gold-coated
sensor chip. The sample is incubated with anti-DA antibody, introduced to the sensor
chip, and optical sensorgrams recorded; unbound antibodies interact with the immobilized
DA to produce a change in the amount of reflected light and thus indirectly indicate the
amount of toxin in the sample. The chips are reusable and can be regenerated with sodium
hydroxide solution. The assay is highly sensitive, with a LOD of 0.1 ng/mL, although it is
important to note that this is with DA prepared in buffer and not in shellfish sample.
Campbell et al. showed the proof of principle of PSP detection utilizing different
antibody and receptor binders [138] whereby this was followed up by Fonfría et al. in
the development of the inhibition-based competitive SPR assay to measure PSP toxins in
mussels, oysters, cockles, scallops and clams [148]. Anti-GTX2/3 antibodies were used in
conjunction with a STX-carboxymethylated dextran, gold-coated sensor chip. The assay
was able to quantify STX and GTX2/3, as well as a number of their analogues, ranging
from 2 to 50 ng/mL. Unfortunately, the SPR biosensor gave a 5-fold higher measurement
of the toxins for some samples compared to the MBA and HPLC, showing poor correlation
with reference methods. This was due to the antibody having a high affinity for the less
potent toxins GTX5 and C1/C2. More recently, the method was refined by Campbell et al.
using an anti-STX antibody which resulted in improved correlation with data obtained
from HPLC (92% agreement) and MBA (96% agreement) methods, taking 6 min to run, and
accommodating up to 40 samples per hour [141]. Furthermore, it has an LOD of 120 µg/kg
for STX in mussels and has been validated in single-laboratory studies to accredited
standards [141] and proven in principle within a pilot interlaboratory study [145].
SPR assays have also been used for the detection of DA in clams [149] OA in mus-
sels [150], and for the multiplexing of PSP toxins, OA, and DA in algal and seawater
samples [151] and shellfish matrices as a move towards the optoelectronic mouse [152].
There has been little work with SPR for emerging toxins. Yakes et al. developed an
SPR assay to detect PLTX in grouper and clams [146]. This assay can detect sub-ng levels of
PLTX, well below the EFSA proposed limit. Campbell et al. have developed and validated
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an SPR assay to detect TTX [140]. This assay can detect TTX levels as low as 200 µg/kg
and each chip is capable of running over 800 samples in total. The assay was validated in
single-laboratory studies to AOAC standards for gastropods and puffer fish and can detect
TTX levels 10-times lower than the permissible limit set by the Japanese government. Most
recently, a field applicable SPR biosensor based on antibody inhibition assay to detect DA
in the seawater was reported as to be highly sensitive tool. This sensor was able to detect
DA at low concentrations (0.1–2 ng/mL). However, this prototype has certain limitations
i.e multiplexing the assay increasing of the detection range and reproducibility [144]. SPR
assays have a lot of advantages over other, more traditional methods. They are label-free,
rapid, automated, require small amounts of sample, and provide real-time measurements.
Furthermore, sensor chips are reusable and can be multiplexed to detect multiple toxins
in a single run. Unfortunately, however, SPR was initially dominated by Biacore SPR
systems and on acquisition with GE Healthcare the food sector was no longer seen as a
lucrative market for the use of the technology due to the initial investment in expense
of the technology required with only large multinational organizations able to afford
the technology for food safety analysis. Furthermore, the equipment requires regular
maintenance, and is not particularly portable for in situ analysis for this application as
requested by producers. For this reason research in this area wound down and other
technologies were explored for enhanced portability. There was some work to develop this
technique in a miniature version [149], however, this technology still requires extensive
validation and has not shown its initial promise in this field for commercialization.
Nonetheless, SPR remains a useful tool for antibody selection for these toxins and in
assessing single antibodies, cocktails of antibodies or bispecific antibodies for selectivity and
specificity towards toxin mixtures relative to their total toxicity in the mouse bioassay [139].
5.1.4. Electrochemical Biosensors
Electrochemical biosensors can analyse the contents of a biological sample and convert
biological information into an electronic signal that can be easily processed and interpreted.
Electrochemical assays can be highly sensitive, and their implementation is versatile.
Bratakou et al. describe a STX immunosensor, which incorporates a STX antibody on a
lipid bilayer, that is then added to a graphene nanosheet electrode. A silver reference
electrode allows a potentiometric electrochemical measurement to be detected when toxin
binds [153]. The sensor was tested with mussels and oysters, has a run time of up to 20 min,
and can be regenerated for re-use.
Leonardo et al. developed a competitive-based electrochemical immunosensor aimed
at detecting AZA and analogues [154]. Anti-AZA antibodies are immobilised to protein
G or avidin-coated electrodes on screen-printed carbon 8-electrode arrays. The sample
is premixed with HRP-conjugated AZA-1 and added to the sensor; free AZAs compete
with the conjugated AZA-1 to bind to the immobilised antibody. HRP substrate reduc-
tion gives an electrochemical signal that is inversely proportional to the amount of free
AZA in the sample. The assay achieves a broad dynamic range capable of detecting
AZA and numerous analogues below the MRL of 160 µg/kg, including AZAs 1–10 and
potentially AZA carboxy congeners. Whilst the detection capabilities of protein G and
avidin-immobilised anti-AZA antibody were similar, when a regeneration step was added,
the avidin-bound anti-AZA antibody survived to a much higher degree, allowing sensor
re-use up to 6 times. Furthermore, when the assay was miniaturised, the quantities of AZA
antibody was significantly reduced; this is beneficial given the low availability of AZA
toxin for antibody development.
Zamolo, et al. describe a different approach, a novel hybrid system combining a
sandwich immunoassay and electrochemiluminescence (ECL) to detect PLTX [155]. In
this assay, measured ECL is directly proportional to PTX concentration, and PTX can be
detected in both mussel and algal samples at concentrations as low as 220 ng/mL.
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5.1.5. Planar Waveguide Cartridges
McNamee et al. applied an MBio cartridge to simultaneously identify five different
marine and freshwater toxins from a single sample [156]. The cartridge combines planar
waveguide with fluorescence and functions similar to an LFIA as described above: it is a
competition-based assay whereby toxin conjugates are spotted onto a plastic slide, making
the signal inversely proportional to the amount of toxin present in the sample. Uniquely,
this sensor uses fluorescently labelled reporter antibodies. Fluorescent reporters can be
more sensitive than traditional gold reporters; thus, it takes less sample to generate a
positive result. The test zone can be smaller, in this case, a spot instead of a line, and you
can multiplex more tests on a single cartridge.
The test developed by McNamee et al. can detect up to five different marine and
freshwater toxins on a single cartridge: STX, DA, OA, microcystin-LR and analogues, and
cylindrospermopsin. The test uses antibodies that recognise a broad range of analogues for
each toxin, potentially making the test more sensitive than LC in some instances where
the sample contains very low levels of multiple different congeners in the same family.
Multiplexing did not seem to significantly alter each individual test’s sensitivity and toxin
can be detected in both algal and seawater samples in 15 min; further testing is on-going to
extend this to shellfish samples.
Reverté et al. used the same system to detect TTX [157]. This test uses the same
competitive-based format and can detect TTX levels as low as 0.4–3.29 µg/g in puffer-
fish tissue.
Planar waveguide cartridges are promising tools as second generation lateral flow
devices for the robust, on site detection of marine biotoxins; they are rapid, sensitive, and
multiple toxins can be screened on a single plastic cartridge. The cartridges are single
use; they cannot be regenerated, which raises concerns about the amount of plastic waste
generated by multiple samples. Furthermore, due to the fluorescent nature of these tests,
they require a special reader to analyze the results. That said, both of these concerns can be
addressed as the technology matures and miniaturization occurs.
5.2. Enzyme Inhibition-Based Biosensors
Campàs and Marty haven taken a different approach, utilizing protein phosphatase 2A
(PP2A) immobilized to a polymer-coated graphite electrode to detect OA in algal samples.
PP2A is the biological target of OA; the reversible inhibition of PP2A is the mechanism of
action of OA. The authors were able to measure PP2A activity using chronoamperometry
as an indirect measurement of OA levels [158]. Similarly, Zhou et al. developed another
alternative approach for the detection of OA using PP2A inhibition [159]. Their approach
utilized disposable carbon nanotubes on a screen-printed electrode containing immobilized
PP2A for assessing mussels. The carbon nanotube method offered a greater dynamic range
of 1300 µg/L, with an LOD of 0.55 µg/L.
5.3. Aptamers-Based Biosensor
Aptamer-based biosensors (aptasensors), are emerging as one of the most high-
throughput, sensitive and specific POST methods, and most recently it has been pointed out
as one of the best candidates for marine toxin detection [160]. Therefore, aptamers are a po-
tential synthetic solution to replace receptors and antibodies and whereby electrochemical
techniques have been shown to be more successful in their application. Gao et al. com-
bined a biolayer inferometry (BLI) with aptamers to detect STX, GTXs, and PLTX [161–163].
These again are competitive-based assays, whereby toxin is immobilised onto the biosensor
surface and signal is inversely proportional to the amount of toxin in the sample. Uniquely,
Gao, et al. used HRP-labelled aptamers as biorecognition reporters. Aptamers are smaller
than monoclonal antibodies (mAbs) and thus may be used to increase signal efficiency [161].
Most recently, Chinnappan et al. reported robust and highly sensitive graphene oxide
(GO) as the fluorescence sensing platform for probing the high affinity of an aptamer for
the detection of CYN toxin from water. In this study, it has been shown that the limit of
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detection using a short derived aptamer (obtained from a long wild-type CYN-sensing
aptamer) is 6-fold lower (17 pM) than the longer aptamer [164]. The current development
of aptasensors has reached the stage of ultra-sensitivity and amongst the others are one of
the most prospective biosensor systems [160]. For example, Qiange et al. demonstrated an
ultra-sensitive (LOD 3 fg/mL) and fast (30 min) colorimetric gold nanoparticle aptasensor
for the detection of STX from water [165].
6. Prospective Trends and Technologies
There are a number of emergent technologies that can also be applied to marine toxin
detection and some of these are adaptations to current methods. Among the other POST
methods, detection using a smartphone has been reviewed most recently for food safety
applications as a sensitive prospective technology as the smartphone can be used as a
portable, handheld reader for field tests. Additional filters or lenses can be added to the
camera to improve image quality, and software or apps can be designed to interpret data,
display results, and backup information to the cloud [166]. Moreover, two other studies
reported the development of promising smartphones technologies to detect OA and STX
biotoxins with two different homemade applications iStrip [167] and iPlate [168]. In the
study performed by Fang et al. a smartphone-based system connecting with competitive
immunoassay strips was designed as a robust POST method to detect these two biotoxins
with high sensitivity and specificity (evaluated LOD was 2.8 ng/mL for OA and 9.8 ng/mL
for STX) [167]. In turn, the approach shown by Su et al. reported an improved and sensitive
field applicable biochemical detection method, as an indirect competitive ELISA assay,
with a smartphone based portable system as a Bionic e-Eye [168].
Other groups are miniaturizing current technology to make it more portable and ac-
cessible on-site. Traditional SPR equipment, as well as analytical detection instruments and
ELISA plate readers are all bulky, heavy, and impossible to use in the field. Chinowsky et al.
have miniaturized the technology and developed a SPR the size of a small briefcase that
can be used for field research [169]. Most recently, miniaturized micro HPLC (µHPLC) or
LC systems were developed to perform high-throughput analysis at point-of-care. These
new systems would have indisputable advantages for use in marine toxin detection due to
their shorter time of analysis (increased separation speed) and lower costs (low samples
or reagents consumption) of analysis than traditional HPLC and LC systems [170]. Ad-
ditionally, the traditional ELISA plate reader has also a POST replacement. Jensen et al.
developed a miniaturized ELISA plate reader for measuring the optical density of 96-well
plates. The advantages of this equipment are its small size, sensitivity and due to the
addition of a wireless communication module there is the possibility to monitor multiple
devices in real-time [171]. Another interesting approach which might replace the tradi-
tional ELISA plate reader for marine toxin detection was reported by Berg et al. who
developed a handheld, cost-effective, smartphone-based colorimetric microplate reader.
This instrument uses a 3D-printed opto-mechanical attachment to hold and illuminate
a 96-well plate using a light-emitting-diode (LED) array. Light is transmitted through
each well, and is then collected via 96 individual optical fibers [172]. The benefits of this
user-friendly microplate reader is the speed of analysis (1 min), accuracy and interpretation
obtained results using a smartphone [172].
Some groups are looking at completely different diagnostic approaches, which rely
on selection and application of different kinds of biorecognition molecules. For example,
instead of using antibodies, phage-derived peptides have been explored for marine toxin
detection in the past [173–175]. Since the first description of phage-display was in 1985, this
technology evolved and revolutionized drug discovery, biomolecular interaction, enzymes
optimization and development of biosensors through the development of biorecognition
molecules [176]. This technology enables us to discover completely new molecules, such
as peptides, other binding proteins or scaffolds, which can be used for a selected target
and applied on sensor platform with high efficacy [176]. An interesting approach was
reported by Shriver-Lake et al. for the detection of two marine biotoxins (DA and STX)
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where a recombinant antibody (scFv) was applied for the sensitive and specific detection
within an xMAP assay (microsphere-based competitive immunoassay) [177]. Another
promising approach using recombinant antibodies and a Lab-On-A-Disc (LOAD) platform
was reported by Maguire et al. for the detection of DA and STX. This platform was reported
to detect both marine biotoxins with high sensitivity and specificity with an analysis time
of 30 min [178]. Many groups are currently investigating other biorecognition molecules
such as aptamers, for use in marine toxin detection [179–182], whereby the selection of
these biomolecules is obtained through the Systematic evolution of ligands by exponential
enrichment (SELEX) process. It is possible to replace antibodies in traditional immunoassay
formats with these types of small molecules, or to use them to develop new types of assays,
such as the open-sandwich immunoassay for PSP toxin detection [175].
Another prospective new trend in the detection of marine biotoxins is the use of
synthesized, novel nanoparticles to develop nanosensors and other assays. The use of
nanomaterials means that electrochemical biosensors can be miniaturized and become
portable, an important criterion for on-site screening. Although there is still uncertainty
regarding the best strategies for assay development e.g., which nanomaterials to use or how
to best immobilize antibodies, electrochemical biosensors present a promising candidate
for rapid on-site screening for marine toxins in shellfish. Specific properties including
their compact nature, relatively quick assay time, capacity for regeneration, and high
sensitivity make them ideal for on-site use. Nelis et al. has shown a proof-of-concept for
the detection of domoic acid evaluating different nanomaterials for this purpose using the
Psalmsens portable sensor [183] and furthermore that it can be applied for the detection
of okadaic acid [184]. Though futuristically where this type of sensor might excel would
be in the environmental sample processors for remote sensing. Another study performed
by Gholami et al. [185] pointed out the development of a nanosensor for the sensitive
and specific detection of maitotoxin (MTX) using novel synthesized carbon quantum dots
(CQDs) and gold nanoparticles (AuNPs) using fluorescence resonance energy transfer
(FRET) as a sensing method. The main advantages of this sensor was the high specificity
for MTX detection from matrix and a LOD, which was evaluated to be 1−600 pmol/L and
0.3 pmol/L [185].
There have been efforts to circumvent the requirement of toxin standard as an im-
munogen; for example, through the generation of anti-idiotypic antibodies. Anti-idiotypic
antibodies are raised against antibodies that are specific to the analyte of interest. As such,
anti-idiotypic antibodies may present chemical structures similar to the analyte, perhaps
providing a suitable substitute for competitive assays [186–188]. Advantages of the use
anti-idiotypic antibodies have been recently pointed out by Schulz et al. where these
biorecognition molecules were used for an electrochemical multiplex (fiveplex) biochip
assay for the detection of low molecular weight toxins including STX with high sensitivity
(1.2 ng/mL) and recovery [189].
7. Challenges for Sample Preparation
Noticeably, there is a lack of emergent multiplex technology. Shellfish can be contam-
inated with multiple toxins at the same time and multi-toxin detection in a single assay
such as an electronic mouse would be hugely beneficial to shellfish producers and con-
sumers [190]. Though some limitations in the evaluation of new biosensor approaches for
this application can be in the accessibility to suitable antibodies or alternative binders and
sufficient toxin for the preparation of competitive chip surfaces through direct conjugation
of the toxin or the use of toxin protein conjugates.
In addition the shellfish matrix and chemistry of marine toxins is complex, and thus,
it can be difficult to isolate particular analytes of interest. Non-specific moieties can inhibit
or mask target analytes, making them difficult to detect, or conversely enhance the toxin
signal, over-estimating toxin presence. As such, toxin extraction in the sample preparation
is a crucial first step in any detection assay to ensure the target analyte is available for
recognition. This is further complicated in multiplex assays; shellfish toxins exhibit key
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differences in their solubility: OA, DTXs, and AZAs are lipophilic, whereas, PSTs, and DA
are hydrophilic. Furthermore, different toxin derivatives within each group can exhibit
varied solubility [191]. Solvent-based extractions are widely used, where shellfish tissue is
homogenised and extracted with a solvent. Importantly, for multiplex assays, the choice of
solvent must ensure that it isolates each of these toxin groups and all the relevant analogues.
Alcohol-based solvent extraction is one of the most common methods when extracting
toxins from shellfish flesh prior to analysis. Methanol has been used widely for extraction
of regulated lipophilic toxins such as OA, DTXs, AZAs, YTXs and PTXs, as well as other
lipophilic toxin groups such as the cyclic imines and palytoxins. Detection of OA-group
esters requires an additional alkaline hydrolysis step to account for the added acetyl
group [101,117,128]. Alternatively, ethanol has been used to extract OA, DA, and STX for
detection by LC-MS/MS and ELISA [81]. Jawaid et al. were able to extract DA and STX
using distilled water for detection by LFIA [125,127]. In terms of extraction protocols that
are practical for portable, field-based applications, distilled water or simple buffer solutions
would be ideal extraction mediums, whereas alcohol-based solvents of appropriate purity
are highly flammable controlled substances and cannot be easily acquired by shellfish
growers or novice end users and are more difficult for distribution in kits.
Studies assessing multiple toxins in shellfish often utilize SPE for both hydrophilic
toxin [59,192] and lipophilic toxin extraction [193]. These are not practical however for
on-site applications.
Traditional SPE can prove ineffective when the analyte and other matrix components
share chemical or physical characteristics, or when they are extremely contaminated.
Immunoaffinity columns (IACs) use monoclonal antibodies (mAbs) to enrich analytes,
potentially resulting in a more sensitive analysis. Due to the highly specific nature of mAbs,
IACs can remove the majority of interfering matrix elements whilst also enhancing the
availability of the toxins. Puech et al. developed an IAC for the extraction of DSP toxins in
shellfish, prior to analysis by high performance LC-fluorimetry [194]. Similarly, Chen et al.
have made an IAC for enriching DA prior to LC-MS/MS analysis [195]. In a slightly
different approach, Devlin et al. coupled an anti-STX antibody to hollow glass magnetic
microspheres in order to enrich mussel samples for detection by high performance LC
(HPLC) [196]. A similar approach has also been used for determining STX levels in human
urine [197]. IAC technology is very promising, however, mAbs are expensive to develop
and produce, which limits the IAC’s potential. Additionally, SPE in general still requires
specialised equipment and can be labour intensive.
After SPE, many protocols incorporate a dilution step prior to the assay. This ensures
that the toxin concentration is within the assay’s dynamic range whilst also further diluting
non-specific molecules to reduce matrix interference. However, this leads to another
significant hurdle to the development of multiplex assays: the disparity between the action
levels that have been set for each toxin. For example, OA-group toxins have an action level
of 160 µg/kg, and DA has an action level of 20,000 µg/kg; it can be difficult to ascertain
a single dilution factor which will simultaneously ensure each toxin is detected with
sufficient sensitivity. Therefore, the sample preparation is continuously a bottle neck for the
multiplexing of any targets but is more complex in foodstuffs rather than liquids and when
varying action levels are set compared to being banned substances like veterinary drug
residues in other fields of application. Achieving a simple novice end user preparatory
method is key for any of the technologies described but particularly for on site applications
where equipment and experience can be limited.
8. Procedural Practicalities for End User Needs
HABs remain a frequent occurrence throughout the world, contaminating shellfish
produce, putting consumer health at risk, forcing harvesting site closures, and inflicting
substantial economic damage. Currently approved regulatory methods for detection of
Lipophilic, PSP and ASP toxins include chemical detection methods such as LC-MS/MS,
LC-FLD and LC-UV. While the chromatography-based reference methods are accurate,
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they are costly, time-consuming, and require specialized equipment with trained personnel.
Although the replacement of the mouse bioassay has been achieved which drove this
innovation there is a great need for screening methods that follow the QuEChERS principle
in being quick, easy, cheap, rugged, and safe to facilitate on-site testing by shellfish produc-
ers, to allow them to make early and informed decisions about their produce. Similarly,
alternative methods have focused on one toxin family in general and whereby the use
of multiple tests on site to cover all toxins is also not practically feasible for the shellfish
industry. Ideally, the industry wish to have at their disposal one simple test that covers all
toxins and ensures that there product is safe for harvest and distribution. Hence, the drive
towards multiplex analysis in this field, but this comes also with additional challenges.
Presently, commercially available screening methods predominantly use ELISA and
LFIA technologies (Table 2). Whilst ELISA offers accuracy and relatively high throughput;
it often requires a few hours to complete and it is not particularly feasible as an on-site
screening method, given the need to use a range of laboratory equipment, reagents and
consumables. Additionally, screening for multiple toxins requires multiple tests to be
run, which increases the cost, time, reagents, and amount of sample needed to screen
stock. Alternatively, the LFIA is very simple to use, requires only minimal training,
and is relatively very quick to perform, in most cases less than 30 min from receiving a
sample to obtaining a result. But unfortunately, these tests only offer qualitative or at best
semi-quantitative results, and similar to the ELISA, each toxin requires its own device
and accompanying sample preparation procedure. New biosensors are being developed
and validated to offer rapid, sensitive, and often portable methods of screening shellfish
toxins. These include electrochemical sensors, surface plasmon resonance, fluorometry,
and microfluidic devices. A summary of these methods is given in Table 3. A majority
of these alternatives use highly specific antibody-based recognition of toxins. Immune
recognition is not without its limitations; for example, it is very difficult to obtain an
antibody that is cross-reactive with all associated toxin analogues to the degree that mirrors
their relative toxicity as determined from a mouse bioassay or upcoming oral toxicity
studies. Additionally, all toxins do not appear in all regions worldwide (Table 1) and
whereby the end user may request custom designed devices for their needs with the ability
to detect only a selection of problematic regulated toxins. Furthermore, unfortunately,
many of these assays still require expensive, specialized, equipment and are not suitable
for rapid, on-site testing.
Most of the proposed screening methods are reliant on the availability of a toxin
standard. The standard is often used both as an immunogen for antibody production or
directly in competitive inhibition-based assays. This represents a significant hurdle in their
development and especially in their production at a commercial scale as certain shellfish
toxins are recognized as highly poisonous and thus are highly controlled substances.
Sample preparation is a critical first step to screening shellfish toxins and can be
the crucial bottleneck in the development of any method. Sample preparation methods
must be relatively simple, quick, and safe if they are to be employed on-site. This greatly
limits the options available to test-kit developers when determining which solvents or
equipment to use in order to overcome the interferences associated with these complex
sample matrices. For example, the current accepted extraction methods for DSP toxins rely
on methanol and/or ethanol. However, these are highly flammable controlled substances
that are difficult to store and transport. As such, many commercially available kits do
not supply extraction solvents, leaving it up to the end user to source and supply their
own. This makes testing more onerous, more expensive, and more confusing for shellfish
producers. As such, shellfish producers and assay manufacturers alike would benefit from
the development of alternative extraction methods. Ideally, new extraction methods would
have as few steps as possible, will be easily achievable on site, and will use non-solvent
extractions that can be bundled with the assay. This means the methods must be safe to
perform without specialist equipment, the solvents must be safe to store in small quantities,
and everything must be easily transported—all whilst maintaining great efficiency to
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extract a majority of the toxins present. Other studies have reported methods to extract
multiple groups of toxin from one sample for analysis but whereby different dilutions may
need to be applied to the different methods for the different families of toxins to achieve
the correct sensitivity [81,195].
9. Conclusions and Future Outlook
Progress in the field of portable toxin testing for industry is rapid where toxins are
available as standards and many promising technologies have been developed, each with
their own strengths and weaknesses. Many of these assays would benefit from miniatur-
ization to make them portable and accessible on-site. Furthermore, many of these assays
require further testing in new matrices e.g., the full range of bivalve species, gastropods
and crustaceans, optimization and validation of protocols to an appropriate standard,
and comparison against the current reference methods. It will be important to perform
collaborative validation studies that assess interlaboratory performance characteristics and
also verify the test kit components are robust and viable across a full range of environ-
ments and following transportation. Different shellfish species thrive in different waters
across the globe, from freezing cold brackish lakes and estuaries to highly saline, warm
tropical lagoons, and testing equipment needs to be able to function under a wide range
of environmental conditions to accommodate the different farmed species. For example,
environmental temperature, humidity, salinity, and light density are all important condi-
tions that can influence test results. Moreover, saltwater is extremely corrosive, and testing
equipment should ideally be water- and corrosion-resistant. It will additionally be vital
to consult and validate the tests to the end user requirements for their ability to be fit for
purpose on site.
Going forward, it will be most important to design highly accurate quantitative
solutions that can give shellfish producers an accurate assessment of contamination levels
in shellfish produce on their site at the time of testing. This would allow producers to follow
immediate trends and make an informed decision about the state of a current contamination
event or even predict an upcoming event. Together, tools designed for practical usage
on site will save shellfish producers time and money, protect consumers, boost consumer
confidence, and help ensure the availability of freshly caught, toxin-free shellfish. However,
these diagnostic tools for toxins should not be considered in isolation: a holistic approach
combining satellite imagery, POST rapid diagnostics and other developing tools [24] for
HAB detection could aid the understanding of our oceans in relation to climate and
environmental conditions moving towards early warning systems that allow enhanced
management and control to complement the data generated by official control testing
programmes. Suitable infrastructure and handling capacity will also be required on-site to
allow these management systems to benefit shellfish farmers.
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